Evanston Investments Inc. dba Evanston Advisors Buys 102 Shares of HealthSouth Corporation (HLS)
Evanston Investments Inc. dba Evanston Advisors increased its stake in HealthSouth Corporation (NYSE:HLS) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,359 shares of the company’s stock after buying an additional 102 shares during the period. Evanston Investments Inc. dba Evanston Advisors owned 0.07% of HealthSouth Corporation worth $3,502,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in HealthSouth Corporation by 4.6% in the first quarter. Vanguard Group Inc. now owns 7,204,375 shares of the company’s stock valued at $308,419,000 after buying an additional 318,619 shares during the period. William Blair Investment Management LLC increased its position in HealthSouth Corporation by 13.9% in the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after buying an additional 525,767 shares during the period. Bank of New York Mellon Corp increased its position in HealthSouth Corporation by 1.6% in the second quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock valued at $70,597,000 after buying an additional 23,480 shares during the period. Principal Financial Group Inc. increased its position in HealthSouth Corporation by 10.1% in the second quarter. Principal Financial Group Inc. now owns 1,147,210 shares of the company’s stock valued at $55,524,000 after buying an additional 105,681 shares during the period. Finally, Wellington Management Group LLP increased its position in HealthSouth Corporation by 4,377.7% in the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock valued at $42,599,000 after buying an additional 972,859 shares during the period. 93.10% of the stock is currently owned by hedge funds and other institutional investors.
HealthSouth Corporation (NYSE:HLS) traded up 2.87% during mid-day trading on Thursday, hitting $45.54. The company had a trading volume of 104,651 shares. The firm has a market capitalization of $4.50 billion, a P/E ratio of 16.60 and a beta of 0.61. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71. The company has a 50-day moving average price of $44.43 and a 200 day moving average price of $44.52.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. During the same period last year, the firm earned $0.69 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. Equities analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.26%. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 35.29%.
HLS has been the topic of several recent research reports. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $50.00 price objective on shares of HealthSouth Corporation in a research note on Thursday, August 3rd. KeyCorp initiated coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating on the stock. BidaskClub raised HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Mizuho raised their price objective on HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a research note on Monday, July 10th. Finally, Zacks Investment Research cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. Two analysts have rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $49.43.
In other news, CEO Mark J. Tarr sold 22,625 shares of HealthSouth Corporation stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.